Clinical Trial Update: Autologous Bone Marrow Stem Cell Transfer in Patients With Chronical Critical Limb Ischemia and Diabetic Foot [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating autologous bone marrow stem cell transfer in patients with chronic critical limb ischemia and diabetic foot has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Diabetic Foot

Drugs mentioned

• Autologous bone marrow stem cell transfer

Snippet

Sponsor: University Hospital Ostrava | Conditions: Critical Limb Ischemia | Phase 2 | Status: COMPLETED